Emphysema reversed in rats

August 1997
CMAJ: Canadian Medical Association Journal;08/01/97, Vol. 157 Issue 3, p241
Academic Journal
States that all-trans-retinoic acid reverses emphysema in rats according to research in Washington. Reference to an article in the 1997 issue of `Nature Med'; The suggestion of human treatment with the acid compound.


Related Articles

  • Quantitative Assessment of Emphysema Severity in Histological Lung Analysis. Marcos, J.; Muñoz-Barrutia, Arrate; Ortiz-de-Solórzano, Carlos; Cristóbal, Gabriel // Annals of Biomedical Engineering;Oct2015, Vol. 43 Issue 10, p2515 

    Emphysema is a characteristic component of chronic obstructive pulmonary disease (COPD), which has been pointed out as one of the main causes of mortality for the next years. Animal models of emphysema are employed to study the evolution of this disease as well as the effect of treatments. In...

  • Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? D'hulst, An I.; Maes, Tania; Bracke, Ken R.; Demedts, Ingel K.; Tournoy, Kurt G.; Joos, Guy F.; Brusselle, Guy G. // Respiratory Research;2005, Vol. 6, p1 

    Background: Chronic obstructive pulmonary disease is associated with a chronic inflammatory response of the host to chronic exposure to inhaled toxic gases and particles. Although inflammatory cells of both the innate and adaptive immune system infiltrate the lungs in pulmonary emphysema and...

  • Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Lucattelli, Monica; Bartalesi, Barbara; Cavarra, Eleonora; Fineschi, Silvia; Lunghi, Benedetta; Martorana, Piero A.; Lungarella, Giuseppe // Respiratory Research;2005, Vol. 6, p83 

    Background: The separation of emphysema from fibrosis is not as clear-cut as it was thought in early studies. These two pathologies may be present at the same time in human lungs and in mice either instilled with elastolytic enzymes or bleomycin or exposed to cigarette-smoke. According to a...

  • Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease. Ken-Ichiro Tanaka; Shota Kurotsu; Teita Asano; Naoki Yamakawa; Daisuke Kobayashi; Yasunobu Yamashita; Hiroshi Yamazaki; Tomoaki Ishihara; Hiroshi Watanabe; Toru Maruyama; Hidekazu Suzuki; Tohru Mizushima // Scientific Reports;3/28/2014, p1 

    We recently proposed that mepenzolate bromide (mepenzolate) would be therapeutically effective against chronic obstructive pulmonary disease (COPD) due to its both anti-inflammatory and bronchodilatory activities. In this study, we examined the benefits and adverse effects associated with...

  • Novel therapeutic approach for pulmonary emphysema using gelatin microspheres releasing basic fibroblast growth factor in a canine model. Chang, Sung; Yokomise, Hiroyasu; Matsuura, Natsumi; Gotoh, Masashi; Tabata, Yasuhiko // Surgery Today;Aug2014, Vol. 44 Issue 8, p1536 

    Purposes: The prognosis of patients with emphysema is poor as there is no truly effective treatment. Our previous study showed that the alveolar space was smaller and the microvessel density was higher in a canine emphysema model after the intrapulmonary arterial administration of gelatin...

  • Genetic emphysema can be misdiagnosed as allergy, asthma or bronchitis.  // Executive Health's Good Health Report;Jul95, Vol. 31 Issue 10, p5 

    Focuses on genetic emphysema. Causes; Symptoms; Importance of early detection; Risk factors; Contact information.

  • BREATHLESS. Baird, Ralph // Saturday Evening Post;May/Jun93, Vol. 265 Issue 3, p30 

    Presents the recollections of the author, a dying emphysema patient, on why he started smoking cigarettes, how they became part of his life, and the illness he contracted as a result. How he became interested in smoking because stars smoked in their films; Pro-smoking messages; How he maintained...

  • Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. Clauss, Matthias; Voswinckel, Robert; Rajashekhar, Gangaraju; Sigua, Ninotchka L; Fehrenbach, Heinz; Rush, Natalia I; Schweitzer, Kelly S; Yildirim, Ali Ö; Kamocki, Krzysztof; Fisher, Amanda J; Gu, Yuan; Safadi, Bilal; Nikam, Sandeep; Hubbard, Walter C; Tuder, Rubin M; Twigg, Homer L 3rd; Presson, Robert G; Sethi, Sanjay; Petrache, Irina // Journal of Clinical Investigation;Jul2012, Vol. 122 Issue 7, p2703 

    Pulmonary emphysema is a disease characterized by alveolar cellular loss and inflammation. Recently, excessive apoptosis of structural alveolar cells has emerged as a major mechanism in the development of emphysema. Here, we investigated the proapoptotic and monocyte chemoattractant cytokine...

  • Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. Wilson, Andrew A.; Murphy, George J.; Hamakawa, Hiroshi; Kwok, Letty W.; Srinivasan, Sreedevi; Hovav, Avi-Hai; Mulligan, Richard C.; Amar, Salomon; Suki, Bela; Kotton, Darrell N. // Journal of Clinical Investigation;Jan2010, Vol. 120 Issue 1, p379 

    Directed gene transfer into specific cell lineages in vivo is an attractive approach for both modulating gene expression and correcting inherited mutations such as emphysema caused by human alpha1 antitrypsin (hAAT) deficiency. However, somatic tissues are mainly comprised of heterogeneous,...

  • Lung-Volume—Reduction Surgery. Pakhale, Smita S.; Gutierrez, Carlos // New England Journal of Medicine;9/4/2003, Vol. 349 Issue 10, p999 

    A letter to the editor is presented in response to the report on the National Emphysema Treatment Trial, published in the May 22, 2003 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics